BriaCell’s Bria-ABC Joins Roster of US-Enrolled Breast Cancer Trials
BriaCell Therapeutics’ (TSX:BCT,NASDAQ:BCTX) Phase 3 Bria-ABC study has been included in a roundup of breast cancer clinical trials…
Rewriting the Patient Journey: GLP‑1 Drugs and the Rise of Oral Therapies
Weight loss drugs continue to play out in the global market, with forecasts estimated at a value of…